Portfolio company
Epignostix
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops AI-powered software for molecular tumour classification to help pathologists and clinicians provide precise cancer diagnoses and personalised treatment plans.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DoMore Diagnostics
This company develops artificial intelligence software for digital pathology to help oncologists and pathologists provide personalised cancer treatment paths for patients.
AI Pathology
This company develops artificial intelligence software for cancer diagnosis and digital pathology image analysis to support pathologists and laboratories.
Epify
This company develops epigenetic biomarkers to enable early cancer detection and personalised oncology for medical professionals and patients.
Aignostics
Aignostics develops AI-powered digital pathology software and foundation models for biopharmaceutical companies, academic researchers and clinical laboratories to improve disease diagnosis and drug development.
StratifAI
This company develops multimodal artificial intelligence biomarkers to predict cancer recurrence risks from pathology slides for oncologists and pharmaceutical organisations.
Panakeia
The company develops artificial intelligence software to provide rapid molecular cancer biomarker analysis from tissue images for hospitals and pharmaceutical research organisations.
Paige AI
This company develops artificial intelligence software for computational pathology to assist pathologists and clinicians in diagnosing and treating cancer.
Ibex Medical
This company develops artificial intelligence software for cancer diagnostics to assist pathologists in labs and hospitals with biopsy analysis and quality control.
